Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Amifostine Market 2018, Forecast to 2023

  • GLO2648766
  • 137 Pages
  • July 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.

Scope of the Report:

This report focuses on the Amifostine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.

The worldwide market for Amifostine is expected to grow at a CAGR of roughly 2.1% over the next five years, will reach 54 million US$ in 2023, from 48 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Clinigen Group

Sun Pharmaceutical

Taj Pharmaceuticals

Merro Pharmaceutical

Luye Pharma

Mingren Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

400mg/Dose

500mg/Dose

Market Segment by Applications, can be divided into

Head and Neck Cancer Adjuvant Therapy

Others

There are 15 Chapters to deeply display the global Amifostine market.

Chapter 1, to describe Amifostine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Amifostine, with sales, revenue, and price of Amifostine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Amifostine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Amifostine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Amifostine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Amifostine Introduction

1.2 Market Analysis by Type

1.2.1 400mg/Dose

1.2.2 500mg/Dose

1.3 Market Analysis by Applications

1.3.1 Head and Neck Cancer Adjuvant Therapy

1.3.2 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Clinigen Group

2.1.1 Business Overview

2.1.1.1 Clinigen Group Description

2.1.1.2 Clinigen Group Headquarter, Main Business and Finance Overview

2.1.2 Clinigen Group Amifostine Product Introduction

2.1.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.1.2.2 Amifostine Product Information

2.1.3 Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.1 Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.2 Global Clinigen Group Amifostine Market Share in 2017

2.2 Sun Pharmaceutical

2.2.1 Business Overview

2.2.1.1 Sun Pharmaceutical Description

2.2.1.2 Sun Pharmaceutical Headquarter, Main Business and Finance Overview

2.2.2 Sun Pharmaceutical Amifostine Product Introduction

2.2.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.2.2.2 Amifostine Product Information

2.2.3 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.1 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.2 Global Sun Pharmaceutical Amifostine Market Share in 2017

2.3 Taj Pharmaceuticals

2.3.1 Business Overview

2.3.1.1 Taj Pharmaceuticals Description

2.3.1.2 Taj Pharmaceuticals Headquarter, Main Business and Finance Overview

2.3.2 Taj Pharmaceuticals Amifostine Product Introduction

2.3.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.3.2.2 Amifostine Product Information

2.3.3 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.1 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.2 Global Taj Pharmaceuticals Amifostine Market Share in 2017

2.4 Merro Pharmaceutical

2.4.1 Business Overview

2.4.1.1 Merro Pharmaceutical Description

2.4.1.2 Merro Pharmaceutical Headquarter, Main Business and Finance Overview

2.4.2 Merro Pharmaceutical Amifostine Product Introduction

2.4.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.4.2.2 Amifostine Product Information

2.4.3 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.1 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.2 Global Merro Pharmaceutical Amifostine Market Share in 2017

2.5 Luye Pharma

2.5.1 Business Overview

2.5.1.1 Luye Pharma Description

2.5.1.2 Luye Pharma Headquarter, Main Business and Finance Overview

2.5.2 Luye Pharma Amifostine Product Introduction

2.5.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.5.2.2 Amifostine Product Information

2.5.3 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.1 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.2 Global Luye Pharma Amifostine Market Share in 2017

2.6 Mingren Pharma

2.6.1 Business Overview

2.6.1.1 Mingren Pharma Description

2.6.1.2 Mingren Pharma Headquarter, Main Business and Finance Overview

2.6.2 Mingren Pharma Amifostine Product Introduction

2.6.2.1 Amifostine Production Bases, Sales Regions and Major Competitors

2.6.2.2 Amifostine Product Information

2.6.3 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.1 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.2 Global Mingren Pharma Amifostine Market Share in 2017

3 Global Amifostine Market Competition, by Manufacturer

3.1 Global Amifostine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Amifostine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global Amifostine Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Amifostine Manufacturer Market Share in 2017

3.4.2 Top 5 Amifostine Manufacturer Market Share in 2017

3.5 Market Competition Trend

4 Global Amifostine Market Analysis by Regions

4.1 Global Amifostine Sales, Revenue and Market Share by Regions

4.1.1 Global Amifostine Sales by Regions (2013-2018)

4.1.2 Global Amifostine Revenue by Regions (2013-2018)

4.2 North America Amifostine Sales, Revenue and Growth Rate (2013-2018)

4.3 Europe Amifostine Sales, Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Amifostine Sales, Revenue and Growth Rate (2013-2018)

4.5 South America Amifostine Sales, Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Amifostine Sales, Revenue and Growth Rate (2013-2018)

5 North America Amifostine by Countries, Type, Application and Manufacturers

5.1 North America Amifostine Sales, Revenue and Market Share by Countries

5.1.1 North America Amifostine Sales by Countries (2013-2018)

5.1.2 North America Amifostine Revenue by Countries (2013-2018)

5.1.3 United States Amifostine Sales and Growth Rate (2013-2018)

5.1.4 Canada Amifostine Sales and Growth Rate (2013-2018)

5.1.5 Mexico Amifostine Sales and Growth Rate (2013-2018)

5.2 North America Amifostine Sales and Revenue (Value) by Manufacturers (2016-2017)

5.2.1 North America Amifostine Sales by Manufacturers (2016-2017)

5.2.2 North America Amifostine Revenue by Manufacturers (2016-2017)

5.3 North America Amifostine Sales, Revenue and Market Share by Type (2013-2018)

5.3.1 North America Amifostine Sales and Sales Share by Type (2013-2018)

5.3.2 North America Amifostine Revenue and Revenue Share by Type (2013-2018)

5.4 North America Amifostine Sales, Revenue and Market Share by Application (2013-2018)

5.4.1 North America Amifostine Sales and Sales Share by Application (2013-2018)

5.4.2 North America Amifostine Revenue and Revenue Share by Application (2013-2018)

6 Europe Amifostine by Countries, Type, Application and Manufacturers

6.1 Europe Amifostine Sales, Revenue and Market Share by Countries

6.1.1 Europe Amifostine Sales by Countries (2013-2018)

6.1.2 Europe Amifostine Revenue by Countries (2013-2018)

6.1.3 Germany Amifostine Sales and Growth Rate (2013-2018)

6.1.4 UK Amifostine Sales and Growth Rate (2013-2018)

6.1.5 France Amifostine Sales and Growth Rate (2013-2018)

6.1.6 Russia Amifostine Sales and Growth Rate (2013-2018)

6.1.7 Italy Amifostine Sales and Growth Rate (2013-2018)

6.2 Europe Amifostine Sales and Revenue (Value) by Manufacturers (2016-2017)

6.2.1 Europe Amifostine Sales by Manufacturers (2016-2017)

6.2.2 Europe Amifostine Revenue by Manufacturers (2016-2017)

6.3 Europe Amifostine Sales, Revenue and Market Share by Type (2013-2018)

6.3.1 Europe Amifostine Sales and Sales Share by Type (2013-2018)

6.3.2 Europe Amifostine Revenue and Revenue Share by Type (2013-2018)

6.4 Europe Amifostine Sales, Revenue and Market Share by Application (2013-2018)

6.4.1 Europe Amifostine Sales and Sales Share by Application (2013-2018)

6.4.2 Europe Amifostine Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific Amifostine by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific Amifostine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Amifostine Sales by Countries (2013-2018)

7.1.2 Asia-Pacific Amifostine Revenue by Countries (2013-2018)

7.1.3 China Amifostine Sales and Growth Rate (2013-2018)

7.1.4 Japan Amifostine Sales and Growth Rate (2013-2018)

7.1.5 Korea Amifostine Sales and Growth Rate (2013-2018)

7.1.6 India Amifostine Sales and Growth Rate (2013-2018)

7.1.7 Southeast Asia Amifostine Sales and Growth Rate (2013-2018)

7.2 Asia-Pacific Amifostine Sales and Revenue (Value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific Amifostine Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific Amifostine Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific Amifostine Sales, Revenue and Market Share by Type (2013-2018)

7.3.1 Asia-Pacific Amifostine Sales and Sales Share by Type (2013-2018)

7.3.2 Asia-Pacific Amifostine Revenue and Revenue Share by Type (2013-2018)

7.4 Asia-Pacific Amifostine Sales, Revenue and Market Share by Application (2013-2018)

7.4.1 Asia-Pacific Amifostine Sales and Sales Share by Application (2013-2018)

7.4.2 Asia-Pacific Amifostine Revenue and Revenue Share by Application (2013-2018)

8 South America Amifostine by Countries, Type, Application and Manufacturers

8.1 South America Amifostine Sales, Revenue and Market Share by Countries

8.1.1 South America Amifostine Sales by Countries (2013-2018)

8.1.2 South America Amifostine Revenue by Countries (2013-2018)

8.1.3 Brazil Amifostine Sales and Growth Rate (2013-2018)

8.1.4 Argentina Amifostine Sales and Growth Rate (2013-2018)

8.1.5 Colombia Amifostine Sales and Growth Rate (2013-2018)

8.2 South America Amifostine Sales and Revenue (Value) by Manufacturers (2016-2017)

8.2.1 South America Amifostine Sales by Manufacturers (2016-2017)

8.2.2 South America Amifostine Revenue by Manufacturers (2016-2017)

8.3 South America Amifostine Sales, Revenue and Market Share by Type (2013-2018)

8.3.1 South America Amifostine Sales and Sales Share by Type (2013-2018)

8.3.2 South America Amifostine Revenue and Revenue Share by Type (2013-2018)

8.4 South America Amifostine Sales, Revenue and Market Share by Application (2013-2018)

8.4.1 South America Amifostine Sales and Sales Share by Application (2013-2018)

8.4.2 South America Amifostine Revenue and Revenue Share by Application (2013-2018)

9 Middle East and Africa Amifostine by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa Amifostine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Amifostine Sales by Countries (2013-2018)

9.1.2 Middle East and Africa Amifostine Revenue by Countries (2013-2018)

9.1.3 Saudi Arabia Amifostine Sales and Growth Rate (2013-2018)

9.1.4 UAE Amifostine Sales and Growth Rate (2013-2018)

9.1.5 Egypt Amifostine Sales and Growth Rate (2013-2018)

9.1.6 Nigeria Amifostine Sales and Growth Rate (2013-2018)

9.1.7 South Africa Amifostine Sales and Growth Rate (2013-2018)

9.2 Middle East and Africa Amifostine Sales and Revenue (Value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa Amifostine Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa Amifostine Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa Amifostine Sales, Revenue and Market Share by Type (2013-2018)

9.3.1 Middle East and Africa Amifostine Sales and Sales Share by Type (2013-2018)

9.3.1 Middle East and Africa Amifostine Revenue and Revenue Share by Type (2013-2018)

9.4 Middle East and Africa Amifostine Sales, Revenue and Market Share by Application (2013-2018)

9.4.1 Middle East and Africa Amifostine Sales and Sales Share by Application (2013-2018)

9.4.2 Middle East and Africa Amifostine Revenue and Revenue Share by Application (2013-2018)

10 Global Amifostine Market Segment by Type

10.1 Global Amifostine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Amifostine Sales and Market Share by Type (2013-2018)

10.1.2 Global Amifostine Revenue and Market Share by Type (2013-2018)

10.2 400mg/Dose Sales Growth and Price

10.2.1 Global 400mg/Dose Sales Growth (2013-2018)

10.2.2 Global 400mg/Dose Price (2013-2018)

10.3 500mg/Dose Sales Growth and Price

10.3.1 Global 500mg/Dose Sales Growth (2013-2018)

10.3.2 Global 500mg/Dose Price (2013-2018)

11 Global Amifostine Market Segment by Application

11.1 Global Amifostine Sales Market Share by Application (2013-2018)

11.2 Head and Neck Cancer Adjuvant Therapy Sales Growth (2013-2018)

11.3 Others Sales Growth (2013-2018)

12 Amifostine Market Forecast (2018-2023)

12.1 Global Amifostine Sales, Revenue and Growth Rate (2018-2023)

12.2 Amifostine Market Forecast by Regions (2018-2023)

12.2.1 North America Amifostine Market Forecast (2018-2023)

12.2.2 Europe Amifostine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Amifostine Market Forecast (2018-2023)

12.2.4 South America Amifostine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Amifostine Market Forecast (2018-2023)

12.3 Amifostine Market Forecast by Type (2018-2023)

12.3.1 Global Amifostine Sales Forecast by Type (2018-2023)

12.3.2 Global Amifostine Market Share Forecast by Type (2018-2023)

12.4 Amifostine Market Forecast by Application (2018-2023)

12.4.1 Global Amifostine Sales Forecast by Application (2018-2023)

12.4.2 Global Amifostine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Amifostine Picture

Table Product Specifications of Amifostine

Figure Global Amifostine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)

Figure Global Amifostine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)

Figure Global Sales Market Share of Amifostine by Types in 2017

Figure 400mg/Dose Picture

Table Major Manufacturers of 400mg/Dose

Figure 500mg/Dose Picture

Table Major Manufacturers of 500mg/Dose

Figure Amifostine Sales Market Share by Applications in 2017

Figure Head and Neck Cancer Adjuvant Therapy Picture

Figure Others Picture

Figure United States Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure France Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure UK Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure China Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure India Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Amifostine Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Amifostine Revenue (Value) and Growth Rate (2013-2023)

Table Clinigen Group Headquarter, Established, Main Business and Finance Overview (2017)

Table Clinigen Group Amifostine Production Bases, Sales Regions and Major Competitors

Table Clinigen Group Amifostine Product

Table Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Clinigen Group Amifostine Sales Market Share in 2017

Figure Global Clinigen Group Amifostine Revenue Market Share in 2017

Table Sun Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)

Table Sun Pharmaceutical Amifostine Production Bases, Sales Regions and Major Competitors

Table Sun Pharmaceutical Amifostine Product

Table Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Sun Pharmaceutical Amifostine Sales Market Share in 2017

Figure Global Sun Pharmaceutical Amifostine Revenue Market Share in 2017

Table Taj Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)

Table Taj Pharmaceuticals Amifostine Production Bases, Sales Regions and Major Competitors

Table Taj Pharmaceuticals Amifostine Product

Table Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Taj Pharmaceuticals Amifostine Sales Market Share in 2017

Figure Global Taj Pharmaceuticals Amifostine Revenue Market Share in 2017

Table Merro Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)

Table Merro Pharmaceutical Amifostine Production Bases, Sales Regions and Major Competitors

Table Merro Pharmaceutical Amifostine Product

Table Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Merro Pharmaceutical Amifostine Sales Market Share in 2017

Figure Global Merro Pharmaceutical Amifostine Revenue Market Share in 2017

Table Luye Pharma Headquarter, Established, Main Business and Finance Overview (2017)

Table Luye Pharma Amifostine Production Bases, Sales Regions and Major Competitors

Table Luye Pharma Amifostine Product

Table Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Luye Pharma Amifostine Sales Market Share in 2017

Figure Global Luye Pharma Amifostine Revenue Market Share in 2017

Table Mingren Pharma Headquarter, Established, Main Business and Finance Overview (2017)

Table Mingren Pharma Amifostine Production Bases, Sales Regions and Major Competitors

Table Mingren Pharma Amifostine Product

Table Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Mingren Pharma Amifostine Sales Market Share in 2017

Figure Global Mingren Pharma Amifostine Revenue Market Share in 2017

Table Global Amifostine Sales by Manufacturer (2016-2017)

Figure Global Amifostine Sales Market Share by Manufacturer in 2016

Figure Global Amifostine Sales Market Share by Manufacturer in 2017

Table Global Amifostine Revenue by Manufacturer (2016-2017)

Figure Global Amifostine Revenue Market Share by Manufacturer in 2016

Figure Global Amifostine Revenue Market Share by Manufacturer in 2017

Table Global Amifostine Price by Manufacturer (2016-2017)

Figure Top 3 Amifostine Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Amifostine Manufacturer (Revenue) Market Share in 2017

Figure Global Amifostine Sales and Growth Rate (2013-2018)

Figure Global Amifostine Revenue and Growth Rate (2013-2018)

Table Global Amifostine Sales by Regions (2013-2018)

Table Global Amifostine Sales Market Share by Regions (2013-2018)

Table Global Amifostine Revenue by Regions (2013-2018)

Figure Global Amifostine Revenue Market Share by Regions in 2013

Figure Global Amifostine Revenue Market Share by Regions in 2017

Figure North America Amifostine Sales and Growth Rate (2013-2018)

Figure North America Amifostine Revenue and Growth Rate (2013-2018)

Figure Europe Amifostine Sales and Growth Rate (2013-2018)

Figure Europe Amifostine Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Amifostine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Amifostine Revenue and Growth Rate (2013-2018)

Figure South America Amifostine Sales and Growth Rate (2013-2018)

Figure South America Amifostine Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Amifostine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Amifostine Revenue and Growth Rate (2013-2018)

Figure North America Amifostine Revenue and Growth Rate (2013-2018)

Table North America Amifostine Sales by Countries (2013-2018)

Table North America Amifostine Sales Market Share by Countries (2013-2018)

Figure North America Amifostine Sales Market Share by Countries in 2013

Figure North America Amifostine Sales Market Share by Countries in 2017

Table North America Amifostine Revenue by Countries (2013-2018)

Table North America Amifostine Revenue Market Share by Countries (2013-2018)

Figure North America Amifostine Revenue Market Share by Countries in 2013

Figure North America Amifostine Revenue Market Share by Countries in 2017

Figure United States Amifostine Sales and Growth Rate (2013-2018)

Figure Canada Amifostine Sales and Growth Rate (2013-2018)

Figure Mexico Amifostine Sales and Growth Rate (2013-2018)

Table North America Amifostine Sales by Manufacturer (2016-2017)

Figure North America Amifostine Sales Market Share by Manufacturer in 2016

Figure North America Amifostine Sales Market Share by Manufacturer in 2017

Table North America Amifostine Revenue by Manufacturer (2016-2017)

Figure North America Amifostine Revenue Market Share by Manufacturer in 2016

Figure North America Amifostine Revenue Market Share by Manufacturer in 2017

Table North America Amifostine Sales by Type (2013-2018)

Table North America Amifostine Sales Share by Type (2013-2018)

Table North America Amifostine Revenue by Type (2013-2018)

Table North America Amifostine Revenue Share by Type (2013-2018)

Table North America Amifostine Sales by Application (2013-2018)

Table North America Amifostine Sales Share by Application (2013-2018)

Table North America Amifostine Revenue by Application (2013-2018)

Table North America Amifostine Revenue Share by Application (2013-2018)

Figure Europe Amifostine Revenue and Growth Rate (2013-2018)

Table Europe Amifostine Sales by Countries (2013-2018)

Table Europe Amifostine Sales Market Share by Countries (2013-2018)

Table Europe Amifostine Revenue by Countries (2013-2018)

Figure Europe Amifostine Revenue Market Share by Countries in 2016

Figure Europe Amifostine Revenue Market Share by Countries in 2017

Figure Germany Amifostine Sales and Growth Rate (2013-2018)

Figure UK Amifostine Sales and Growth Rate (2013-2018)

Figure France Amifostine Sales and Growth Rate (2013-2018)

Figure Russia Amifostine Sales and Growth Rate (2013-2018)

Figure Italy Amifostine Sales and Growth Rate (2013-2018)

Table Europe Amifostine Sales by Manufacturer (2016-2017)

Figure Europe Amifostine Sales Market Share by Manufacturer in 2016

Figure Europe Amifostine Sales Market Share by Manufacturer in 2017

Table Europe Amifostine Revenue by Manufacturer (2016-2017)

Figure Europe Amifostine Revenue Market Share by Manufacturer in 2016

Figure Europe Amifostine Revenue Market Share by Manufacturer in 2017

Table Europe Amifostine Sales by Type (2013-2018)

Table Europe Amifostine Sales Share by Type (2013-2018)

Table Europe Amifostine Revenue by Type (2013-2018)

Table Europe Amifostine Revenue Share by Type (2013-2018)

Table Europe Amifostine Sales by Application (2013-2018)

Table Europe Amifostine Sales Share by Application (2013-2018)

Table Europe Amifostine Revenue by Application (2013-2018)

Table Europe Amifostine Revenue Share by Application (2013-2018)

Figure Asia-Pacific Amifostine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Amifostine Sales by Countries (2013-2018)

Table Asia-Pacific Amifostine Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Amifostine Sales Market Share by Countries 2017

Table Asia-Pacific Amifostine Revenue by Countries (2013-2018)

Figure Asia-Pacific Amifostine Revenue Market Share by Countries 2017

Figure China Amifostine Sales and Growth Rate (2013-2018)

Figure Japan Amifostine Sales and Growth Rate (2013-2018)

Figure Korea Amifostine Sales and Growth Rate (2013-2018)

Figure India Amifostine Sales and Growth Rate (2013-2018)

Figure Southeast Asia Amifostine Sales and Growth Rate (2013-2018)

Table Asia-Pacific Amifostine Sales by Manufacturer (2016-2017)

Figure Asia-Pacific Amifostine Sales Market Share by Manufacturer in 2016

Figure Asia-Pacific Amifostine Sales Market Share by Manufacturer in 2017

Table Asia-Pacific Amifostine Revenue by Manufacturer (2016-2017)

Figure Asia-Pacific Amifostine Revenue Market Share by Manufacturer in 2016

Figure Asia-Pacific Amifostine Revenue Market Share by Manufacturer in 2017

Table Asia-Pacific Amifostine Sales by Type (2013-2018)

Table Asia-Pacific Amifostine Sales Share by Type (2013-2018)

Table Asia-Pacific Amifostine Revenue by Type (2013-2018)

Table Asia-Pacific Amifostine Revenue Share by Type (2013-2018)

Table Asia-Pacific Amifostine Sales by Application (2013-2018)

Table Asia-Pacific Amifostine Sales Share by Application (2013-2018)

Table Asia-Pacific Amifostine Revenue by Application (2013-2018)

Table Asia-Pacific Amifostine Revenue Share by Application (2013-2018)

Figure South America Amifostine Revenue and Growth Rate (2013-2018)

Table South America Amifostine Sales by Countries (2013-2018)

Table South America Amifostine Sales Market Share by Countries (2013-2018)

Figure South America Amifostine Sales Market Share by Countries in 2017

Table South America Amifostine Revenue by Countries (2013-2018)

Table South America Amifostine Revenue Market Share by Countries (2013-2018)

Figure South America Amifostine Revenue Market Share by Countries in 2017

Figure Brazil Amifostine Sales and Growth Rate (2013-2018)

Figure Argentina Amifostine Sales and Growth Rate (2013-2018)

Figure Colombia Amifostine Sales and Growth Rate (2013-2018)

Table South America Amifostine Sales by Manufacturer (2016-2017)

Figure South America Amifostine Sales Market Share by Manufacturer in 2016

Figure South America Amifostine Sales Market Share by Manufacturer in 2017

Table South America Amifostine Revenue by Manufacturer (2016-2017)

Figure South America Amifostine Revenue Market Share by Manufacturer in 2016

Figure South America Amifostine Revenue Market Share by Manufacturer in 2017

Table South America Amifostine Sales by Type (2013-2018)

Table South America Amifostine Sales Share by Type (2013-2018)

Table South America Amifostine Revenue by Type (2013-2018)

Table South America Amifostine Revenue Share by Type (2013-2018)

Table South America Amifostine Sales by Application (2013-2018)

Table South America Amifostine Sales Share by Application (2013-2018)

Table South America Amifostine Revenue by Application (2013-2018)

Table South America Amifostine Revenue Share by Application (2013-2018)

Figure Middle East and Africa Amifostine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Amifostine Sales by Countries (2013-2018)

Table Middle East and Africa Amifostine Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Amifostine Sales Market Share by Countries in 2017

Table Middle East and Africa Amifostine Revenue by Countries (2013-2018)

Table Middle East and Africa Amifostine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2013

Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Amifostine Sales and Growth Rate (2013-2018)

Figure UAE Amifostine Sales and Growth Rate (2013-2018)

Figure Egypt Amifostine Sales and Growth Rate (2013-2018)

Figure Nigeria Amifostine Sales and Growth Rate (2013-2018)

Figure South Africa Amifostine Sales and Growth Rate (2013-2018)

Table Middle East and Africa Amifostine Sales by Manufacturer (2016-2017)

Figure Middle East and Africa Amifostine Sales Market Share by Manufacturer in 2016

Figure Middle East and Africa Amifostine Sales Market Share by Manufacturer in 2017

Table Middle East and Africa Amifostine Revenue by Manufacturer (2016-2017)

Figure Middle East and Africa Amifostine Revenue Market Share by Manufacturer in 2016

Figure Middle East and Africa Amifostine Revenue Market Share by Manufacturer in 2017

Table Middle East and Africa Amifostine Sales by Type (2013-2018)

Table Middle East and Africa Amifostine Sales Share by Type (2013-2018)

Table Middle East and Africa Amifostine Revenue by Type (2013-2018)

Table Middle East and Africa Amifostine Revenue Share by Type (2013-2018)

Table Middle East and Africa Amifostine Sales by Application (2013-2018)

Table Middle East and Africa Amifostine Sales Share by Application (2013-2018)

Table Middle East and Africa Amifostine Revenue by Application (2013-2018)

Table Middle East and Africa Amifostine Revenue Share by Application (2013-2018)

Table Global Amifostine Sales by Type (2013-2018)

Table Global Amifostine Sales Share by Type (2013-2018)

Table Global Amifostine Revenue by Type (2013-2018)

Table Global Amifostine Revenue Share by Type (2013-2018)

Figure Global 400mg/Dose Sales Growth (2013-2018)

Figure Global 400mg/Dose Price (2013-2018)

Figure Global 500mg/Dose Sales Growth (2013-2018)

Figure Global 500mg/Dose Price (2013-2018)

Table Global Amifostine Sales by Application (2013-2018)

Table Global Amifostine Sales Share by Application (2013-2018)

Figure Global Head and Neck Cancer Adjuvant Therapy Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Amifostine Sales, Revenue and Growth Rate (2018-2023)

Table Global Amifostine Sales Forecast by Regions (2018-2023)

Table Global Amifostine Market Share Forecast by Regions (2018-2023)

Figure North America Sales Amifostine Market Forecast (2018-2023)

Figure Europe Sales Amifostine Market Forecast (2018-2023)

Figure Asia-Pacific Sales Amifostine Market Forecast (2018-2023)

Figure South America Sales Amifostine Market Forecast (2018-2023)

Figure Middle East and Africa Sales Amifostine Market Forecast (2018-2023)

Table Global Amifostine Sales Forecast by Type (2018-2023)

Table Global Amifostine Market Share Forecast by Type (2018-2023)

Table Global Amifostine Sales Forecast by Application (2018-2023)

Table Global Amifostine Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research